APA

Jenkins D. W., Ross S., Veldman-Jones M., Foltz I. N., Clavette B. C., Manchulenko K., Eberlein C., Kendrew J., Petteruti P., Cho S., Damschroder M., Peng L., Baker D., Smith N. R., Weir H. M., Blakey D. C., Bedian V. & Barry S. T. (20121217). MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo. : Molecular cancer therapeutics.

Chicago

Jenkins David W, Ross Sarah, Veldman-Jones Margaret, Foltz Ian N, Clavette Brandon C, Manchulenko Kathy, Eberlein Cath, Kendrew Jane, Petteruti Philip, Cho Song, Damschroder Melissa, Peng Li, Baker Dawn, Smith Neil R, Weir Hazel M, Blakey David C, Bedian Vahe and Barry Simon T. 20121217. MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo. : Molecular cancer therapeutics.

Harvard

Jenkins D. W., Ross S., Veldman-Jones M., Foltz I. N., Clavette B. C., Manchulenko K., Eberlein C., Kendrew J., Petteruti P., Cho S., Damschroder M., Peng L., Baker D., Smith N. R., Weir H. M., Blakey D. C., Bedian V. and Barry S. T. (20121217). MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo. : Molecular cancer therapeutics.

MLA

Jenkins David W, Ross Sarah, Veldman-Jones Margaret, Foltz Ian N, Clavette Brandon C, Manchulenko Kathy, Eberlein Cath, Kendrew Jane, Petteruti Philip, Cho Song, Damschroder Melissa, Peng Li, Baker Dawn, Smith Neil R, Weir Hazel M, Blakey David C, Bedian Vahe and Barry Simon T. MEDI0639: a novel therapeutic antibody targeting Dll4 modulates endothelial cell function and angiogenesis in vivo. : Molecular cancer therapeutics. 20121217.